Patient‐reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial
BJU International · 2026-06 · 137 (6) · 1088-1096
DOI: 10.1111/bju.70249 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 18.03.2026. Verfasst von Hugo W Schuil und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands. Hauptthemen laut MEDLINE: Nephrostomy, Percutaneous, Stents, Patient Reported Outcome Measures, Ureteral Obstruction. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: leading the change.
Abstract (Originalsprache)
Objective
To compare the effects of percutaneous nephrostomy (PCN) and JJ ureteric stent (JJ) for urinary tract decompression in patients with obstructive urolithiasis on health‐related quality of life (HRQoL), pain scores, urinary symptoms, and patient satisfaction. Patients and Methods In 11 hospitals, 204 patients with obstructive urolithiasis were randomised to JJ or PCN placement. Patient‐reported outcome measures (PROMs) were assessed until stone passage, surgical removal, or at 3 months.
Results
Both PCN and JJ effectively improved HRQoL index scores (PCN: pre‐decompression 0.70, 1 day post‐decompression 0.82, P = 0.003; JJ: pre 0.59, post 0.85, P < 0.001), pain scores (PCN: pre 4.9, post 1.3, P < 0.001; JJ: pre 5.5, post 1.3, P < 0.001), and achieved patient satisfaction (score at discharge PCN: 7.9; JJ: 8.2), with no significant differences between interventions in overall HRQoL (generalised estimating equation [GEE] P = 0.7) or mean daily pain scores (GEE P = 0.4). PCN led to more self‐care difficulties (patients reporting no problems: PCN 74%, JJ 91%, P = 0.023), while JJ recipients reported more urinary symptoms and higher peak pain intensity (pain score PCN: 2.3, JJ: 3.7, between groups P = 0.018). Despite symptoms, more JJ recipients preferred the same intervention in future (60%), than PCN recipients (31%) ( P < 0.001). Survey‐based data collection may introduce response bias (response rate 59%).
Conclusion
In patients with obstructive urolithiasis, urinary decompression with PCN and JJ improved HRQoL and pain comparably. JJ causes more urinary symptoms and peak pain but allows better self‐care. Baseline self‐care and urinary symptoms should guide shared decision‐making. Drainage duration should be minimised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
- Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Clinical Trials Unit, Healthcare Evaluation and Research, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Urology, Meander Medisch Centrum, Amersfoort, The Netherlands.
- Department of Urology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
- Department of Radiology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
ORCID-Profile: Hugo W Schuil, Nora Hendriks, Janneke I M van Uhm, Saskia Weltings
Förderung
- leading the change
Zitieren
APA
Schuil, H. W., Hendriks, N., Duijnhoven, R. G., Oskam, B. C. H., Arends, T. J. H., Duijvesz, D., Horsch, A. D., van der Heij, B., Tjiam, I. M., van Overhagen, H., Lamers, A. B. G. N., van Delden, O. M., Scheepens, W. A., Drossaerts, J. M. A., d'Ancona, F. C. H., Boering, S., van Uhm, J. I. M., van der Meer, R. W., van Roijen, J. H., …, & Kamphuis, G. M. (2026). Patient‐reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial. BJU International, 137(6), 1088-1096. https://doi.org/10.1111/bju.70249
Vancouver
Schuil HW, Hendriks N, Duijnhoven RG, Oskam BCH, Arends TJH, Duijvesz D, et al. Patient‐reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial. BJU International. 2026;137(6):1088-1096. doi:10.1111/bju.70249
BibTeX
@article{Schuil2026,
author = {Schuil, Hugo W and Hendriks, Nora and Duijnhoven, Ruben G and Oskam, Bart C H and Arends, Tom J H and Duijvesz, Diederick and Horsch, Alexander D and van der Heij, Bart and Tjiam, Irene M and van Overhagen, Hans and Lamers, Armand B G N and van Delden, Otto M and Scheepens, Wout A and Drossaerts, Jamie M A and d'Ancona, Frank C H and Boering, Steven and van Uhm, Janneke I M and van der Meer, Rutger W and van Roijen, J Herman and de Kiefte, Martin and Hendrikx, Ad J M and Weltings, Saskia and Pelger, Rob C M and Beerlage, Harrie P and Schout, Barbara M A and Kamphuis, Guido M},
title = {Patient‐reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial},
journal = {BJU International},
year = {2026},
volume = {137},
number = {6},
pages = {1088--1096},
doi = {10.1111/bju.70249}
}
EUVIMED